Standard diagnostic and therapeutic process of IBD-associated anaemia

Czech version

Authors: L. Hrdlička ¹; P. Kohout ²; M. Liberda ³; M. Konečný ⁴; M. Lukáš ¹; Pracovní Skupina Pro Idiopatické Střevní Záněty Čgs Čls Jep
Authors‘ workplace: Klinické a výzkumné centrum pro střevní záněty, ISCARE, Praha ¹; II. interní klinika, Thomayerova nemocnice, Praha ²; Gastroenterologické oddělení, Nemocnice Valašské Meziříčí ³; II. interní klinika gastroenterologická a hepatologická, FN Olomouc ⁴
Published in: Gastroent Hepatol 2012; 66(4): 280-285
Category: IBD: Guidelines

Overview

The below-mentioned guidelines for the diagnosis and therapy of anaemia in IBD patients were generated by the Czech IBD Working Group (Czech Society for Gastroenterology of the Czech Medical Association of Jan Evangelista Purkyně) during a consensus meeting at Šiškův Mlýn near Telč in June 7–8, 2012. The guidelines are based on data coming from recent publications presented in the US and EU, which were broadly discussed in view of the local availability of the mentioned diagnostic and therapeutic recommendations. The final recommended procedure follows the consensus of all members of the IBD Working Group. It presents the current preferred approach to resolving anaemia in IBD patients as well as a recommendation for following up these patients. We hope that this document is a basic platform for the current diagnostic and therapeutic regimen for anaemia in IBD patients.

Key words:
ulcerative colitis – Crohn’s disease – anaemia – iron therapy

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for biomedical papers.

Submitted:
24. 6. 2012

Accepted:
26. 7. 2012

Sources

1. Gasche C, Berstad A, Befrits R et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13(12): 1545–1553.

2. Oustamanolakis P, Koutroubakis IE, Kouromalis EA. Diagnosing anemia in inflammatory bowel disease: Beyond the established markers. J Crohns Colitis 2011; 5(5): 381–391.

3. Gasche C. Anemia in IBD: the overlooked villain. Inflamm Bowel Dis 2000; 6(2): 142–150.

4. Gomollon F, Gisbert JP. Anemia and inflammatory bowel diseases. J World Gastroenterol 2009; 15(37): 4659–4665.

5. Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica 2010; 95(2): 175–178.

6. Bergamaschi G, Di Sabatino A, Albertini R et al. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor--alpha treatment. Haematologica 2010; 95(2): 199–205.

7. Giannini S, Martes C. Anemia in inflammatory bowel disease. Minerva Gastroenterol Dietol 2006; 52(3): 275–291.

8. Kulnigg S, Gasche C. Systematic review: managing anemia in Crohn's disease. Aliment Pharmacol Ther 2006; 24(11–12): 1507–1523.

9. Zhu A, Kaneshiro M, Kaunitz JD. Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective. Dig Dis Sci 2010; 55(3): 548–559.

10. Guagnozzi D, Severi C, Ialongo P et al. Ferritin as a simple indicator of iron deficiency in anemic IBD patients. Inflamm Bowel Dis 2006; 12(2): 150–151.

11. Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol 2010; 7(11): 599–610.

12. Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 2006; 1: S4–S8.

13. Clark SF. Iron deficiency anemia: diagnosis and management. Curr Opin Gastroenterol 2009; 25(2): 122–128.

14. Fernandez-Rodriguez AM, Guindeo--Casasús MC, Molero-Labarta T et al. Diagnosis of iron deficiency in chronic renal failure. Am J Kidney Dis 1999; 34(3): 508–513.

15. Nemeth E, Tuttle MS, Powelson J et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306(5704): 2090–2093.

16. Oustamanolakis P, Koutroubakis IE, Messaritakis I et al. Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2011; 23(3): 262–268.

17. Oustamanolakis P, Koutroubakis IE, Messaritakis I et al. Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease. J Crohns Colitis 2011; 5(4): 295–300.

18. Hart AL, Ng SC. Inflammatory Bowel Disease: An Evidence-based Practical Guide. UK tmf Publishing Ltd. 2012: 259–278.

19. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn´s disease. Aliment Pharmacol Ther 2006; 24(11–12): 1507–1523.

20. Dali-Youcef N, Andres E. An update on cobalamin deficiency in adults. QJM 2009; 102: 17–28.

21. Bátovský M. Súčasný prístup k anemii u pacientov s nešpecifickými črevnými zápalmi. Gastroent Hepatol 2012; 66(2): 131–135.

22. Lee TW, Kolber MR, Fedorak RN et al. Iron replacement therapy in IBD patients with IDA: A systematic review and meta-analysis. J Crohns Colitis 2012; 6(3): 267–275.

23. Evstatiev R, Marteau P, Iqbal T et al. FERGIcor study. Gastroenterology 2011; 141(3): 846–853.